CEACAM1 and neoplasm: Two million control or CEACAM1 shRNA-transduced JEKO-1 cells expressing firefly luciferase were intravenously injected into immunodeficient NOD/SCID/IL2R-Gamma null (NSG) mice, and tumor growth was monitored by whole-body bioluminescence imaging.